PAR 0.00% 22.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-2741

  1. 4,275 Posts.
    lightbulb Created with Sketch. 6782
    Mangoman, a sample size of one certainly comes with its own caveats but our friend Happell is at least one personal example of the potential in the RA space.

    The other link, by association, is of course Alpha Virus related arthritis, like what we have wonderfully observed to date in our RRV/CHIK-V models:


    "The hallmark of alphavirus disease is crippling pain and inflammation of the joints, a similar immunopathology to rheumatoid arthritis". 1

    ...and further:..

    "In the past few years, we have identified many similarities between the pathobiology of infectious arthritis and rheumatoid arthritis."



    This indication will be added, at least from an observation point or off label until an association is made/studied at larger scales.




    DYOR is apt



    Ref
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505659/
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.000(0.00%)
Mkt cap ! $76.95M
Open High Low Value Volume
22.5¢ 23.5¢ 22.0¢ $65.40K 290.2K

Buyers (Bids)

No. Vol. Price($)
13 96390 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 138166 5
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.